Clinical Trial

Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males

Name: Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males — clinical trial record (NCT07450521)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

A randomized, double-blind, placebo-controlled, study to assess the safety, tolerability, and PK of MTX-463 when administered via SC injection in healthy adult males.

Protocol Amendment History 1 change

critical Trial completed 2026-03-31

Trial Details

NCT Number	NCT07450521
Lead Sponsor	Mediar Therapeutics
Conditions	Healthy Adult Male
Enrollment	8 participants
Start Date	2026-02-18
Primary Completion	2026-03-11 (estimated)
Study Completion	2026-03-11 (estimated)
Updated on ClinicalTrials.gov	2026-03-30